ABOUT US

KEY FACTS

  • UK based private company founded in 2013, with an intellectual property portfolio comprising granted patents in multiple countries.
  • Pipeline of 3 medical device technologies under pre-clinical and clinical development
  • Awarded 3 highly competitive British Government grants to date, recognising the potential impact of our innovative technologies.
  • Newtec vascular shareholders include investors from the following funds and investor networks: